A Multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (phascolarctos cinereus): Comparison of three different adjuvants

American Journal of Reproductive Immunology

Volumn 63, Issue 2, 2010, Pages 161-172

  Carey, Alison J ^a   Timms, Peter ^a   Rawlinson, Galit ^b   Brumm, Jacqui ^b   Nilsson, Karen ^b   Harris, Jonathon M ^a   Beagley, Kenneth W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Lone Pine Koala Sanctuary   (Australia)

Author keywords

Adjuvant; Antibody; Chlamydia; Koala

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; ISCOM; MAJOR OUTER MEMBRANE PROTEIN; PROTEIN NRDB; PROTEIN TC0512; TITERMAX GOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHLAMYDIASIS; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; KOALA; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA; CHLAMYDIA INFECTIONS; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; ISCOMS; LYMPHOCYTE ACTIVATION; PHASCOLARCTIDAE; POLOXALENE; VACCINES, SUBUNIT;

EID: 73949155375     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00776.x     Document Type: Article

References (38)

1. McColl KA, Martin RW, Gleeson LJ, Handasyde KA, Lee AK. Chlamydia infection and infertility in the female koala (Phascolarctos cinereus). Vet Rec 1984, 115:655.
2. Canfield PJ, Love DN, Mearns G, Farram E. Chlamydial infection in a colony of captive koalas. Aust Vet J 1991, 68:167-169.
3. Jackson M, White N, Giffard P, Timms P. Epizootiology of Chlamydia infections in two free-range koala populations. Vet Microbiol 1999, 65:255-264.
4. Markey B, Wan C, Hanger J, Phillips C, Timms P. Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus). Vet Microbiol 2007, 120:334-342.
5. Girjes AA, Hugall AF, Timms P, Lavin MF. Two distinct forms of Chlamydia psittaci associated with disease and infertility in Phascolarctos cinereus (koala). Infect Immun 1988, 56:1897-1900.
6. Brown AS, Grice RG. Isolation of Chlamydia psittaci from koalas (Phascolarctos cinereus). Aust Vet J 1984, 61:413.
7. Brown AS, Girjes AA, Lavin MF, Timms P, Woolcock JB. Chlamydial disease in koalas. Aust Vet J 1987, 64:346-350.
8. Osawa R, Carrick FN. Use of a dietary supplement in koalas during systemic antibiotic treatment of chlamydial infection. Aust Vet J 1990, 67:305-307.
9. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004, 72:1843-1855.
10. Wilkinson R, Allanson M, Kolega V, Lawrence D, Neville S. Purification and initial characterisation of koala immunoglobulins. Vet Immunol Immunopathol 1991, 29:189-195.
11. Wilkinson R, Kotlarski I, Barton M. Koala lymphoid cells: analysis of antigen-specific responses. Vet Immunol Immunopathol 1992, 33:237-247.
12. Kitchener AL, Kay DJ, Walters B, Menkhorst P, McCartney CA, Buist JA, Mate KE, Rodger JC. The immune response and fertility of koalas (Phascolarctos cinereus) immunised with porcine zonae pellucidae or recombinant brushtail possum ZP3 protein. J Reprod Immunol 2009, 82:40-47.
13. Warren HS, Vogel FR, Chedid LA. Current status of immunological adjuvants. Annu Rev Immunol 1986, 4:369-388.
14. Grayston JT. Immunisation against trachoma. Pan Am Health Organ Sci Publ 1965, 147:549.
15. Grayston JT, Wang SP. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. [Review] [19 refs]. Sex Transm Dis 1978, 5:73-77.
16. Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM, Gockel CM, Beagley KW. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 2004, 72:1019-1028.
17. Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM, Hansbro PM, Beagley KW. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 2006, 24:355-366.
18. Jackson M, Giffard P, Timms P. Outer membrane protein A gene sequencing demonstrates the polyphylogenetic nature of koala Chlamydia pecorum isolates. Syst Appl Microbiol 1997, 20:187-200.
19. Barker CJ, Beagley KW, Hafner LM, Timms P. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine 2008, 26:1285-1296.
20. McNeilly CL, Beagley KW, Moore RJ, Haring V, Timms P, Hafner LM. Expression library immunization confers partial protection against Chlamydia muridarum genital infection. Vaccine 2007, 25:2643-2655.
21. Wilkinson R, Kotlarski I, Barton M. Further characterisation of the immune response of the koala. Vet Immunol Immunopathol 1994, 40:325-339.
22. Wilkinson R, Kotlarski I, Barton M, Phillips P. Isolation of koala lymphoid cells and their in vitro responses to mitogens. Vet Immunol Immunopathol 1992, 31:21-33.
23. Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci USA 1996, 93:11143-11148.
24. Mitchell CM, Mathews SA, Theodoropoulos C, Timms P. In vitro characterisation of koala Chlamydia pneumoniae: morphology, inclusion development and doubling time. Vet Microbiol 2009, 136:91-99.
25. Caldwell HD, Schachter J. Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun 1982, 35:1024-1031.
26. Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol 2004, 82:497-505.
27. Hunter RL. Overview of vaccine adjuvants: present and future. Vaccine 2002, 3:S7-S12.
28. Kool M, Petrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, Tschopp J. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008, 181:3755-3759.
29. Kool M, Soullie T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008, 205:869-882.
30. Pearse MJ, Drane D. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses. Vaccine 2004, 22:2391-2395.
31. Pearse MJ, Drane D. ISCOMATRIX adjuvant for antigen delivery. Adv Drug Deliv Rev 2005, 57:465-474.
32. Sjolander S, Drane D, Davis R, Beezum L, Pearse M, Cox J. Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine 2001, 19:4072-4080.
33. Malliaros J, Quinn C, Arnold FH, Pearse MJ, Drane DP, Stewart TJ, Macfarlan RI. Association of antigens to ISCOMATRIX adjuvant using metal chelation leads to improved CTL responses. Vaccine 2004, 22:3968-3975.
34. Boyle J, Eastman D, Millar C, Camuglia S, Cox J, Pearse M, Good J, Drane D. The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses. Vaccine 2007, 25:2541-2544.
35. Hu KF, Lovgren-Bengtsson K, Morein B. Immunostimulating complexes (ISCOMs) for nasal vaccination. Adv Drug Deliv Rev 2001, 51:149-159.
36. Villacres MC, Behboudi S, Nikkila T, Lovgren-Bengtsson K, Morein B. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction. Cell Immunol 1998, 185:30-38.
37. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002, 70:2741-2751.
38. Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol 2005, 53:208-214.